Popular Articles

AMT Receives EMEA Orphan Drug Designation For Acute Intermittent Porphyria
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced that the European Medicines Agency has granted Orphan Drug Designation to AMT"s gene therapy product AMT-021 for the treatment of acute intermittent porphyria (AIP).
generic viagra online
Mixed Results From Trials Of DHA In Alzheimer's Disease And Age-Related Cognitive Decline Emphasize The Need For Earlier Detection And Intervention
Results from two large studies using DHA, an omega 3 fatty acid, were reported at the Alzheimer"s Association 2009 International Conference on Alzheimer"s Disease (ICAD 2009) in Vienna.
News of the day
Response Genetics To Present New Data On Lung Cancer Supporting The Use Of Gene Expression To Help Personalize Cancer Therapy Selection
Response Genetics Inc. (Nasdaq: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, will announce the results of separate analyses of KRAS gene mutations and TS and RRM1 gene expression in non-small cell lung cancer (NSCLC) during the 13th World Conference on Lung Cancer, which will be held July 31 to August 4. Results will provide insights into which patient subtypes are most likely to benefit from the commonly prescribed chemotherapies pemetrexed and gemcitabine.
Mental Health

Taking A Hard-Line Approach To Cardiovascular Risks In The Diabetes Patient

When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual"s risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress. "We need to be more aggressive in treating our patients," Howard S. Weintraub, MD, a cardiologist and Clinical Associate Professor of Medicine at NYU Medical School, said. "This requires individualized testing and early intervention." Weintraub suggested that while gathering a patient"s blood sugar data is important, assessing their results on an individual basis is crucial. Doing so may help to proactively identify the "constellation of issues" present in many patients. This means placing more emphasis on the "diabetic state." By assessing factors like high blood pressure, bad cholesterol (LDL), blood sugar, triglycerides and weight, doctors can better predict the multiple cardiovascular risks likely to prey upon a patient. "It"s the physician"s job to interpret all the risk factors and see the big picture," Weintraub said. "And appropriate action should be taken before it"s too late." For more information about preventive health measures and diabetes, download the American College of Endocrinology"s (ACE) "Power of Prevention(R)" magazine here. The magazine features medical information on type 1 and type 2 diabetes, diabetes complications, and tips on how diabetes patients can best prepare for disaster. ACE also issued a comprehensive treatment regimen for patients with prediabetes; a condition affecting more than 56 million Americans, which leaves them at risk for developing type 2 diabetes and cardiovascular complications. About AACE AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. American Association of Clinical Endocrinologists


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):